Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - April 2018

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Ciprofloxacin ear drops (Cetraxal®) has been accepted for restricted use in the treatment of acute otitis externa in adults and children older than 1 year with an intact tympanic membrane, caused by ciprofloxacin susceptible microorganisms. The restriction limits use to when off-label or unlicensed ciprofloxacin formulations would otherwise be used.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - April 2018' on Email Share 'SMC Update - April 2018' on Delicious Share 'SMC Update - April 2018' on Digg Share 'SMC Update - April 2018' on Facebook Share 'SMC Update - April 2018' on reddit Share 'SMC Update - April 2018' on StumbleUpon Share 'SMC Update - April 2018' on Twitter

atomic-wealth

No Comments to “SMC Update - April 2018”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer